BRIEF-Celgene says year off to strong start

Jan 29 (Reuters) - Celgene Corp : * Says early Q1 trends indicate strong start to year * Says plans to initiate 8 new phase i clinical programs in 2015 * Says received Revlimid reimbursement approval in Russia * Says anticipates Revlimid pricing approval in Mexico * Says growth drivers exist to meet or exceed 2015 and longer term forecasts